| A transmembrane leucine zipper is required for activation of the dimeric receptor tyrosine kinase DDR1 NA Noordeen, F Carafoli, E Hohenester, MA Horton, B Leitinger Journal of biological chemistry 281 (32), 22744-22751, 2006 | 154 | 2006 |
| Carbohydrate-responsive element-binding protein (ChREBP) is a negative regulator of ARNT/HIF-1β gene expression in pancreatic islet β-cells NA Noordeen, TK Khera, G Sun, ER Longbottom, TJ Pullen, ... Diabetes 59 (1), 153-160, 2010 | 81 | 2010 |
| Glucose-induced nuclear shuttling of ChREBP is mediated by sorcin and Ca2+ ions in pancreatic β-cells NA Noordeen, G Meur, GA Rutter, I Leclerc Diabetes 61 (3), 574-585, 2012 | 58 | 2012 |
| Ethical responses to the COVID-19 pandemic—lessons from Sri Lanka D Hettiarachchi, N Noordeen, C Gamakaranage, EARBD Somarathne, ... Asian bioethics review 13, 225-233, 2021 | 33 | 2021 |
| Roles of Ca2+ ions in the control of ChREBP nuclear translocation I Leclerc, GA Rutter, G Meur, N Noordeen Journal of Endocrinology 213 (2), 115-122, 2012 | 16 | 2012 |
| The Impact and Challenges of Medical Journalism: A Review N Noordeen, D Hettiarachchi Univ Col Rev 1 (1), 37-46, 2020 | 4 | 2020 |
| Design and implementation of a novel pharmacogenetic assay for the identification of the CYP2D6*10 genetic variant NDK Ranadeva, ND Sirisena, TK Wetthasinghe, N Noordeen, ... BMC Research Notes 15 (1), 104, 2022 | 2 | 2022 |
| A novel tetra-primer ARMS-PCR for genotyping of the OPRM1 gene rs1799971 variant associated with opioid use disorders PJ Wijekumar, NDK Ranadeva, AR Jayamaha, H Herath, N Noorden, ... BMC Research Notes 16 (1), 333, 2023 | | 2023 |
| The Design and Implementation of a Novel Pharmacogenomic Assay to Genotype the CYP3A53 (rs776746) and CYP3A51E (rs4646453) Genetic Variants R Sameem, N Noordeen, S Praveenan, TK Wetthasinghe, ... | | 2023 |
| A Novel Tetra-Primer ARMS-PCR for genotyping of the OPRM 1 gene rs1779791 variant associated with opioid use disorders PJ Wijekumar, NDK Ranadeva, AR Jayamaha, H Herath, N Noorden, ... | | 2023 |
| Nuclear translocation of ChREBP depends of sorcini and calcium ions in the pancreatic beta cell N Noordeen, G Meur, G Rutter, I Leclerc DIABETES & METABOLISM 37, A1-A1, 2011 | | 2011 |
| O1 La translocation nucléaire de ChREBP dépend de sorcin et des ions calciques dans la cellule beta pancréatique N Noordeen, G Meur, G Rutter, I Leclerc Diabetes & Metabolism 37 (1), A1, 2011 | | 2011 |
| Régulation glycémique et diabète N Noordeen, G Meur, G Rutter, I Leclerc Annales d’Endocrinologie 72, 344-345, 2011 | | 2011 |
| Carbohydrate-Responsive Element-Binding Protein (ChREBP) activity is regulated by Ca2+ ions in pancreatic beta cells via soluble resistant-related calcium binding protein (Sorcin) NA Noordeen, G Meur, P Patel, GA Rutter, I Leclerc DIABETOLOGIA 53, S91-S92, 2010 | | 2010 |
| Regulation of the Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT) gene expression by the Carbohydrate-Responsive Element Binding Protein (ChREBP) NA Noordeen, T Khera, G Xavier, GA Rutter, I Leclerc DIABETIC MEDICINE 25, 2008 | | 2008 |
| Investigating the structural domains required for activation of the human discoidin domain receptors, DDR1 and DDR2 NA Noordeen PQDT-Global, 2006 | | 2006 |
